Activated Hepatic Nuclear Factor-κB in Experimental Colitis Regulates CYP2A5 and Metronidazole Disposition

4.6 (479) ·
$ 0.50 ·
In stock

Description

Activated Hepatic Nuclear Factor-κB in Experimental Colitis Regulates  CYP2A5 and Metronidazole Disposition
An NF-κB–driven lncRNA orchestrates colitis and circadian clock
Activated Hepatic Nuclear Factor-κB in Experimental Colitis Regulates  CYP2A5 and Metronidazole Disposition
Activation of PXR by alantolactone ameliorates DSS-induced
Activated Hepatic Nuclear Factor-κB in Experimental Colitis Regulates  CYP2A5 and Metronidazole Disposition
Nitroimidazoles: Molecular Fireworks That Combat a Broad Spectrum
Activated Hepatic Nuclear Factor-κB in Experimental Colitis Regulates  CYP2A5 and Metronidazole Disposition
Mycoplasma gallisepticum escapes the host immune response via gga
Activated Hepatic Nuclear Factor-κB in Experimental Colitis Regulates  CYP2A5 and Metronidazole Disposition
Transcriptional Silencing of the Death Gene BNIP3 by Cooperative
Activated Hepatic Nuclear Factor-κB in Experimental Colitis Regulates  CYP2A5 and Metronidazole Disposition
Geniposide ameliorates TNBS-induced experimental colitis in rats
Activated Hepatic Nuclear Factor-κB in Experimental Colitis Regulates  CYP2A5 and Metronidazole Disposition
The transcription factor hepatocyte nuclear factor 4A acts in the
Activated Hepatic Nuclear Factor-κB in Experimental Colitis Regulates  CYP2A5 and Metronidazole Disposition
New insights into IL-6 family cytokines in metabolism, hepatology
Activated Hepatic Nuclear Factor-κB in Experimental Colitis Regulates  CYP2A5 and Metronidazole Disposition
Activated Hepatic Nuclear Factor-κB in Experimental Colitis

Related products

You may also like

copyright © 2019-2024 tlpa.aero all rights reserved.